Part Of The Solution? PBMs See Opportunities In Medicaid Reform
Executive Summary
Amidst a growing chorus of criticism that pharmacy benefit managers are contributing to the problem of high drug costs, PCMA’s Merritt defends the PBM business model and points to its potential for better managing costs in Medicaid.
You may also be interested in...
Medicaid Drug Formulary Ideas Floated, But US Manufacturers Are Skeptical
Medicaid formularies capable of excluding drugs to drive better rebates could replace the existing drug rebate program, lobbyists suggest, but US manufacturers worry that lawmakers will be leery of losing statutory-based rebates.
US Medicaid Reform: Legislators Caution CMS Nominee About Coverage Loss
Seema Verma is closely identified with Medicaid reform but both Republicans and Democrats expressed concern during her Senate confirmation hearing that reforms not translate into loss of insurance coverage.
GPhA Rebrands As AAM, Hopes To Change Tenor Of Drug Pricing Debate
How is the generic industry like Captain "Sully" trying to land a damaged plane in the Hudson River?